October 22, 2025

Advancing Geriatric Oncology: Where We Have Been and Where We Are Going

The aging population is rapidly growing, with the number of older adults rising steadily each year. In the 1980s, experts predicted a rise in the number of older patients with cancer, yet we were unpr...

The ASCO Post

October 19, 2025

ADC Improves Outcomes for Patients with Advanced Triple-Negative Breast Cancer Who are Ineligible for Immune Checkpoint Inhibitors

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody drug conjugate sacituzumab govitecan compared to standard chemotherapy.

Dana-Farber

October 18, 2025

Novel Treatment Combination Improves Progression-Free Survival in Metastatic, Estrogen-Receptor-Positive HER-2-Negative Breast Cancer

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation selective estrogen receptor degrader and full antagonist, compared to a standard combination approach.

Dana-Farber

October 14, 2025

Rare HeartMate 6 LVAD Saves Patient with Heart Failure After Chemotherapy

When an adverse reaction to chemotherapy sent a patient into heart failure, it took state-of-the-art treatment from an advanced cardiovascular team to save him in time.

Keck Medicine of USC

October 08, 2025

Risk vs. Benefit: Clinical Trial Aims to Identify Patients with Early-Stage NSCLC Who May Not Need Immunotherapy After Surgery

Many patients with early-stage non-small cell lung cancer (NSCLC) are treated post-surgery with the monoclonal antibody durvalumab (brand name Imfinzi) — an FDA-approved regimen.

Roswell Park Comprehensive Cancer Center

October 07, 2025

One woman’s fight against rare appendix cancer

After a shocking stage IV cancer diagnosis, patient found hope at UCI Health and turned her recovery into a mission to help others.

UCI Health

October 06, 2025

More Tattoos, Lower Risk of Melanoma? New Study Investigates

People with more than one tattoo session may have a decreased risk of developing melanoma—with one key caveat, according to a study evaluating over 7,000 individuals.

The ASCO Post

October 03, 2025

Mehran Habibi, M.D., MBA, Named Chief of Breast Surgery at Baptist Health Miami Cancer Institute and Deputy Chief of Breast Surgery for Baptist Health Cancer Care

Mehran Habibi, M.D., MBA, an internationally recognized surgical breast oncologist with over two decades of clinical and academic leadership, has been named chief of breast surgery at Baptist Health Miami Cancer Institute.

Baptist Health South Florida

October 03, 2025

Impact of Proton and Photon Therapies on HRQOL in Breast Cancer

Health-related quality-of-life measurements demonstrated that both proton and photon radiation therapy led to excellent and similar impacts on quality of life for patients with breast cancer undergoin...

The ASCO Post